Literature DB >> 23220967

Lucilia sericata chymotrypsin disrupts protein adhesin-mediated staphylococcal biofilm formation.

Llinos G Harris1, Yamni Nigam, James Sawyer, Dietrich Mack, David I Pritchard.   

Abstract

Staphylococcus aureus and Staphylococcus epidermidis biofilms cause chronic infections due to their ability to form biofilms. The excretions/secretions of Lucilia sericata larvae (maggots) have effective activity for debridement and disruption of bacterial biofilms. In this paper, we demonstrate how chymotrypsin derived from maggot excretions/secretions disrupts protein-dependent bacterial biofilm formation mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220967      PMCID: PMC3568615          DOI: 10.1128/AEM.03689-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  24 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Operative debridement of diabetic foot ulcers.

Authors:  Michael S Golinko; Renta Joffe; Jason Maggi; Dalton Cox; Eashwar B Chandrasekaran; R Marjana Tomic-Canic; Harold Brem
Journal:  J Am Coll Surg       Date:  2008-12       Impact factor: 6.113

3.  The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation.

Authors:  S E Cramton; C Gerke; N F Schnell; W W Nichols; F Götz
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses.

Authors:  Mariena J A van der Plas; Anne M van der Does; Mara Baldry; Heleen C M Dogterom-Ballering; Co van Gulpen; Jaap T van Dissel; Peter H Nibbering; Gerrolt N Jukema
Journal:  Microbes Infect       Date:  2007-01-27       Impact factor: 2.700

5.  Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Alyson Bexfield; Yamni Nigam; Stephen Thomas; Norman A Ratcliffe
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

6.  Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases.

Authors:  Holger Rohde; Christoph Burdelski; Katrin Bartscht; Muzaffar Hussain; Friedrich Buck; Matthias A Horstkotte; Johannes K-M Knobloch; Christine Heilmann; Mathias Herrmann; Dietrich Mack
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

7.  The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin.

Authors:  Martin Christner; Gefion C Franke; Nina N Schommer; Ulrike Wendt; Kim Wegert; Philip Pehle; Gesche Kroll; Christian Schulze; Friedrich Buck; Dietrich Mack; Martin Aepfelbacher; Holger Rohde
Journal:  Mol Microbiol       Date:  2009-11-25       Impact factor: 3.501

8.  The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae).

Authors:  Alyson Bexfield; A Elizabeth Bond; Emily C Roberts; Edward Dudley; Yamni Nigam; Stephen Thomas; Russell P Newton; Norman A Ratcliffe
Journal:  Microbes Infect       Date:  2007-12-28       Impact factor: 2.700

9.  The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation.

Authors:  Rebecca M Corrigan; David Rigby; Pauline Handley; Timothy J Foster
Journal:  Microbiology (Reading)       Date:  2007-08       Impact factor: 2.777

10.  Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions.

Authors:  Llinos G Harris; Alyson Bexfield; Yamni Nigam; Holger Rohde; Norman A Ratcliffe; Dietrich Mack
Journal:  Int J Artif Organs       Date:  2009-09       Impact factor: 1.595

View more
  15 in total

Review 1.  TIME management by medicinal larvae.

Authors:  David I Pritchard; Václav Čeřovský; Yamni Nigam; Samantha F Pickles; Gwendolyn Cazander; Peter H Nibbering; Anke Bültemann; Wilhelm Jung
Journal:  Int Wound J       Date:  2015-07-15       Impact factor: 3.315

2.  Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.

Authors:  David I Pritchard; Alan P Brown
Journal:  Int Wound J       Date:  2013-07-09       Impact factor: 3.315

3.  Targeting microbial biofilms using Ficin, a nonspecific plant protease.

Authors:  Diana R Baidamshina; Elena Y Trizna; Marina G Holyavka; Mikhail I Bogachev; Valeriy G Artyukhov; Farida S Akhatova; Elvira V Rozhina; Rawil F Fakhrullin; Airat R Kayumov
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

4.  First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  F S Masiero; M F K Aquino; M P Nassu; D I B Pereira; D S Leite; P J Thyssen
Journal:  Neotrop Entomol       Date:  2016-10-01       Impact factor: 1.434

5.  Characterisation of the small RNAs in the biomedically important green-bottle blowfly Lucilia sericata.

Authors:  Cherie Blenkiron; Peter Tsai; Lisa A Brown; Vernon Tintinger; Kathryn J Askelund; John A Windsor; Anthony R Phillips
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 6.  Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview.

Authors:  Litao Yan; Jin Chu; Mingshu Li; Xianfeng Wang; Junwei Zong; Xueyang Zhang; Mingzhi Song; Shouyu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-03       Impact factor: 2.629

7.  Selection and Evaluation of Tissue Specific Reference Genes in Lucilia sericata during an Immune Challenge.

Authors:  Andre Baumann; Rüdiger Lehmann; Annika Beckert; Andreas Vilcinskas; Zdeněk Franta
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 8.  Recent advances in developing insect natural products as potential modern day medicines.

Authors:  Norman Ratcliffe; Patricia Azambuja; Cicero Brasileiro Mello
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-06       Impact factor: 2.629

9.  Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens.

Authors:  Jana Bohova; Juraj Majtan; Viktor Majtan; Peter Takac
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-11       Impact factor: 2.629

10.  Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots.

Authors:  Zdeněk Franta; Heiko Vogel; Rüdiger Lehmann; Oliver Rupp; Alexander Goesmann; Andreas Vilcinskas
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.